InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,037.73
(
0.39%
)
US TECH 100
16,948.38
(
0.52%
)
Dow Jones
38,070.22
(
0.44%
)
Brent Oil
83.13
(
-0.50%
)
Bitcoin
59,200.00
(
1.65%
)
Post# of 4860
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

ohm20

Send PM Follow Ignore
Followers 46
Posts 2450
Boards Moderated 0
Alias Born 04/17/2019

ohm20

Re: LionsTact post# 3925

Friday, 06/05/2020 11:48:36 AM

Friday, June 05, 2020 11:48:36 AM

Post# of 4860

Roche's Actemra


IL-6 inhibition only, good luck with that. Combining an antiviral that doesn't kill the virus with a drug that lowers immune response to the virus should make it interesting.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GILD News
More GILD News
InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!